Resident peritoneal macrophages and mast cells are important cellular sites of COX-1 and COX-2 activity during acute peritoneal inflammation

Archivum Immunologiae et Therapiae Experimentalis

Volumn 57, Issue 6, 2009, Pages 459-466

  Kolaczkowska, Elzbieta ^a   Goldys, Anna ^a   Kozakiewicz, Elzbieta ^a   Lelito, Monika ^a   Plytycz, Barbara ^a   Van Rooijen, Nico ^b   Arnold, Bernd ^c  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cyclooxygenase; Peritoneal inflammation; Prostaglandins; Resident peritoneal leukocytes

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; MESSENGER RNA; PROSTAGLANDIN D2; PROSTAGLANDIN E2; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOCYTOCHEMISTRY; INFLAMMATION; MALE; MAST CELL; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PERITONITIS; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ACUTE DISEASE; ANIMALS; CELLS, CULTURED; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGES, PERITONEAL; MALE; MAST CELLS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; PERITONITIS; PROSTAGLANDIN D2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ZYMOSAN;

EID: 70450246995     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-009-0053-6     Document Type: Article

References (31)

1. MN Ajuebor AM Das L Virag, et al. 1999 Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10 J Immunol 162 1685 1691 1:CAS:528:DyaK1MXhtVWqtLY%3D 9973430
2. AM Das RJ Flower M Perretti 1997 Eotaxin-induced eosinophil migration in the peritoneal cavity of ovalbumin-sensitized mice: mechanism of action J Immunol 159 1466 1473 1:CAS:528:DyaK2sXkslKrur4%3D 9233645
3. NS Doherty P Poubelle P Borgeat, et al. 1985 Intraperitoneal injection of zymosan in mice induces pain, inflammation and the synthesis of peptidoleukotrienes and prostaglandin E2 Prostaglandins 30 769 789 10.1016/0090-6980(85)90006-1 1:CAS:528:DyaL28Xjt1Krsg%3D%3D 3001831 (Pubitemid 16199279)
4. JY Fu JL Masferrer K Seibert, et al. 1990 The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes J Biol Chem 265 16737 16740 1:CAS:528:DyaK3cXlvV2lsL0%3D 2120205
5. DW Gilroy PR Colville-Nash D Willis, et al. 1999 Inducible cyclooxygenase may have anti-inflammatory properties Nat Med 5 698 701 10.1038/9550 1:CAS:528:DyaK1MXjs1Klt7Y%3D 10371510 (Pubitemid 29289435)
6. DW Gilroy A Tomlinson DA Willoughby 1998 Differential effects of inhibitors of cyclooxygenase (cyclooxygenase 1 and cyclooxygenase 2) in acute inflammation Eur J Pharmacol 355 211 217 10.1016/S0014-2999(98)00508-1 1:CAS:528:DyaK1cXlsl2ntr8%3D 9760036 (Pubitemid 28404704)
7. M Hamberg B Samuelsson 1973 Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis Proc Natl Acad Sci USA 70 899 903 10.1073/pnas.70.3.899 1:CAS:528:DyaE3sXktl2guro%3D 4514999
8. E Kolaczkowska B Arnold G Opdenakker 2008 Gelatinase B/MMP-9 as an inflammatory marker enzyme in mouse zymosan peritonitis: comparison of phase-specific and cell-specific production by mast cells, macrophages and neutrophils Immunobiology 231 109 124 10.1016/j.imbio.2007.07.005 (Pubitemid 351147069)
9. E Kolaczkowska M Barteczko B Plytycz, et al. 2008 Role of lymphocytes in the course of murine zymosan-induced peritonitis Inflamm Res 57 272 278 10.1007/s00011-007-7131-1 1:CAS:528:DC%2BD1cXnvFGgt7c%3D 18516709
10. E Kolaczkowska M Chadzinska A Scislowska-Czarnecka, et al. 2006 Gelatinase B/matrix metalloproteinase-9 contributes to cellular infiltration in a murine model of zymosan peritonitis Immunobiology 211 137 148 10.1016/j.imbio.2005.08.004 1:CAS:528:DC%2BD28Xkt1Gktb8%3D 16530081 (Pubitemid 43337754)
11. E Kolaczkowska M Chadzinska R Seljelid, et al. 2001 Strain differences in some immune parameters can be obscured by circadian variations and laboratory routines: studies of male C57BL/6J, Balb/c and CB6 F1 mice Lab Anim 35 91 100 10.1258/0023677011911417 1:STN:280:DC%2BD3M7kslGhuw%3D%3D 11201292 (Pubitemid 32061609)
12. E Kolaczkowska M Lelito E Kozakiewicz, et al. 2007 Resident peritoneal leukocytes are important sources of MMP-9 during zymosan peritonitis: superior contribution of macrophages over mast cells Immunol Lett 113 99 106 10.1016/j.imlet.2007.07.017 1:CAS:528:DC%2BD2sXhtF2iurbM 17826846 (Pubitemid 47562124)
13. E Kolaczkowska B Plytycz B Arnold, et al. 2009 Increased cyclooxygenase activity impairs apoptosis of inflammatory neutrophils in mice lacking gelatinase B/matrix metalloproteinase-9 Immunology 128 e262 e274 10.1111/j.1365-2567.2008.02956.x 19175797
14. E Kolaczkowska A Scislowska-Czarnecka M Chadzinska, et al. 2006 Enhanced early vascular permeability in gelatinase B (MMP-9)-deficient mice: putative contribution of COX-1-derived PGE2 of macrophage origin J Leukoc Biol 80 125 132 10.1189/jlb.0106013 1:CAS:528:DC%2BD28XmvVGlu7g%3D 16684893 (Pubitemid 44835533)
15. E Kolaczkowska R Seljelid B Plytycz 2001 Role of mast cells in zymosan-induced peritoneal inflammation in Balb/c and mast cell-deficient WBB6F1 mice J Leukoc Biol 69 33 42 1:CAS:528:DC%2BD3MXlvFCitg%3D%3D 11200065
16. E Kolaczkowska S Shahzidi R Seljelid, et al. 2002 Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinylleukotrienes Inflammation 26 61 71 10.1023/A:1014837110735 1:CAS:528:DC%2BD38Xjs12mt7s%3D 11989789 (Pubitemid 34274484)
17. R Langenbach SG Morham HF Tiano, et al. 1995 Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration Cell 83 483 492 10.1016/0092-8674(95) 90126-4 1:CAS:528:DyaK2MXpt1Olt78%3D 8521478
18. Majno G, Joris I (2004) Cells, tissues, and disease: principles of general pathology. Blackwell, Oxford
19. JL Masferrer BS Zweifel K Seibert, et al. 1990 Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice J Clin Invest 86 1375 1379 10.1172/JCI114850 1:CAS:528:DyaK3cXmt1Cltbk%3D 2120289
20. SB Miller 2006 Prostaglandins in health and disease: an overview Semin Arthritis Rheum 36 37 49 10.1016/j.semarthrit.2006.03.005 1:CAS:528: DC%2BD28Xns1Gkt74%3D 16887467 (Pubitemid 44128595)
21. SG Morham R Langenbach CD Loftin, et al. 1995 Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse Cell 83 473 482 10.1016/0092-8674(95)90125-6 1:CAS:528:DyaK2MXpt1Olt74%3D 8521477
22. TS Rao JL Currie AF Shaffer, et al. 1994 In vivo characterization of zymosan-induced mouse peritoneal inflammation J Pharmacol Exp Ther 269 917 925 1:CAS:528:DyaK2cXksFGktb0%3D 8014878
23. AF Sheibanie JH Yen T Khayrullina, et al. 2007 The proinflammatory effect of prostaglandin E2 in experimental inflammatory bowel disease is mediated through the IL-23->IL-17 axis J Immunol 178 8138 8147 1:CAS:528: DC%2BD2sXmtVKnsbg%3D 17548652
24. DL Simmons RM Botting T Hla 2004 Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition Pharmacol Rev 56 387 437 10.1124/pr.56.3.3 1:CAS:528:DC%2BD2cXotVKjtbY%3D 15317910 (Pubitemid 39096597)
25. DS Straus G Pascual M Li, et al. 2000 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway Proc Natl Acad Sci USA 97 4844 4849 10.1073/pnas.97.9.4844 1:CAS:528:DC%2BD3cXivFKjurY%3D 10781090 (Pubitemid 30238645)
26. E Tchougounova A Lundequist I Fajardo, et al. 2005 A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2 J Biol Chem 280 9291 9296 10.1074/jbc.M410396200 1:CAS:528:DC%2BD2MXitVCiuro%3D 15615702 (Pubitemid 40409621)
27. N Ueno Y Taketomi K Koga, et al. 2008 A negative regulator of delayed prostaglandin D2 production in mouse mast cells Biochim Biophys Acta 1781 415 421 1:CAS:528:DC%2BD1cXps1GlsLk%3D 18656551
28. N van Rooijen A Sanders 1994 Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications J Immunol Methods 174 83 93 10.1016/0022-1759(94)90012-4 8083541 (Pubitemid 124013923)
29. JR Vane 1971 Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs Nat New Biol 231 232 235 1:CAS:528: DyaE3MXltVyjur4%3D 5284360
30. TD Warner JA Mitchell 2004 Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic FASEB J 18 790 804 10.1096/fj.03-0645rev 1:CAS:528:DC%2BD2cXjvVOntrs%3D 15117884 (Pubitemid 38544498)
31. DA Willoughby AR Moore PR Colville-Nash 2000 COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease Lancet 355 646 648 10.1016/S0140-6736(99)12031-2 1:CAS:528:DC%2BD3cXhvVGjsr8%3D 10696997